WANY
ONC

Wealthspire Advisors (New York)’s BeOne Medicines Ltd ONC Stock Holding History

Wealthspire Advisors (New York)’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20
Closed -$6.81K – 3033
2025
Q3 		$6.81K Buy
+20
New +$6.07K ﹤0.01% 2199
2019
Q1 		– Sell
-4
Closed -$1K – 834
2018
Q4 		$1K Buy
+4
New +$530 ﹤0.01% 857

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Wealthspire Advisors (New York)'s ONC Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of BeOne Medicines Ltd (ONC) in Q4 2025, closing a stake of 20 shares — an estimated $6.81K sold.

Wealthspire Advisors (New York) first reported a position in ONC in Q4 2018 and held it in 2 quarters. The position peaked at $6.81K in Q3 2025. 286 funds tracked by Wall St. Rank hold ONC as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining BeOne Medicines Ltd position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 20 BeOne Medicines Ltd shares in Q4 2025, an estimated $6.81K.
  • Wealthspire Advisors (New York) first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 2 quarters.
  • Wealthspire Advisors (New York)'s BeOne Medicines Ltd position peaked at $6.81K in Q3 2025.
  • 286 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.